Science Explorer Interactive view Map
Company · Tel Aviv · Israel

RDD Pharma (Israel)

Research works
3
▲ 80% vs 2013–17
Citations
23
7.0 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: RDD Pharma (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does RDD Pharma (Israel) publish most on?

By volume in 2022–2025: Parkinson's Disease Mechanisms and Treatments, Medication Adherence and Compliance, Urticaria and Related Conditions and Medicine and Dermatology Studies History.

  1. 1 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  2. 2 Medication Adherence and Compliance Family Practice 0 works
  3. 3 Urticaria and Related Conditions Rheumatology 0 works
  4. 4 Medicine and Dermatology Studies History Dermatology 0 works
  5. 5 Dermatology and Skin Diseases Dermatology 0 works
  6. 6 Voice and Speech Disorders Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.5%not open56.5%

World: 28% of research is openly available.

with international co-authors42.6%domestic only57.4%

World: 19% is written across borders.

How has RDD Pharma (Israel)'s research output changed?

Output in 2018–2022 was 80% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tel Aviv

All research institutions in Tel Aviv

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.